DiaMedica Therapeutics Inc.
Pharmaceutical company · Minneapolis, Minnesota, United States · Nasdaq: DMAC
DiaMedica Therapeutics Inc. is a pharmaceutical company headquartered in Minneapolis, Minnesota, United States. Its shares trade on Nasdaq under the ticker DMAC. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2025.
DiaMedica Therapeutics at a glance
What does DiaMedica Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $30.1 million sold (2025).
Frequently asked questions about DiaMedica Therapeutics
Where is DiaMedica Therapeutics headquartered?
DiaMedica Therapeutics Inc. is headquartered in Minneapolis, Minnesota, United States.
What does DiaMedica Therapeutics do?
DiaMedica Therapeutics Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is DiaMedica Therapeutics a public company?
Yes. DiaMedica Therapeutics Inc. trades on Nasdaq under the ticker DMAC.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.